Technology News and Research

RSS

ImmunoGen announces FDA approval of IMGN289 Investigational New Drug

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its Targeted Antibody Payload (TAP) ADC technology, today announced that the Company's x (IND) application has been accepted by the US FDA and is now active.

2 Aug 2013

UCLA researchers develop treatment approach for breast cancer metastasized to brain

Researchers at UCLA's Jonsson Comprehensive Cancer Center (JCCC) have successfully combined cellular therapy and gene therapy in a mouse model system to develop a viable treatment strategy for breast cancer that has metastasized, or spread, to the patient's brain.

2 Aug 2013

BMC, BUSM and JIPMER to jointly research on tuberculosis

Boston Medical Center and Boston University School of Medicine are partnering with the Jawaharlal Institute of Postgraduate Medical Education and Research to study tuberculosis. This research is supported by a five-year, $2.5 million grant from the Indo-U.S. Vaccine Action Program.

2 Aug 2013

Portable device for point-of-care diagnostic testing to detect cancer at earliest stages

Reaching a clinic in time to receive an early diagnosis for cancer -- when the disease is most treatable -- is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.

2 Aug 2013

Breath analysis: Noninvasive way to quickly determine severity of bacterial infections

Breath analysis may prove to be an accurate, noninvasive way to quickly determine the severity of bacterial and other infections, according to a UC Irvine study appearing online today in the open-access journal PLOS ONE.

2 Aug 2013

MAPS method could speed development of new vaccines for serious pathogens

A new method of vaccine design, called the Multiple Antigen Presentation System, may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination.

1 Aug 2013

BD reports quarterly revenues of $2.053 billion for third fiscal quarter

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $2.053 billion for the third fiscal quarter ended June 30, 2013, representing an increase of 3.6 percent from the prior-year period, or 5.1 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 1 Aug 2013

Sequenom CMM, CombiMatrix sign collaboration agreement to market CMA testing for NIPT

Sequenom, Inc., a life sciences company providing innovative diagnostic testing and genetic analysis solutions, and CombiMatrix Corporation, a molecular diagnostics laboratory performing DNA-based testing services for developmental disorders and cancer, today jointly announced that the Sequenom Center for Molecular Medicine LLC and CombiMatrix have entered into a collaboration agreement to market chromosomal microarray analysis testing services to broaden and confirm the results of noninvasive, prenatal testing to physicians and their patients.

1 Aug 2013

'Dark matter' in human genome may play role in cancer biology and cell death

The St. Laurent Institute, a non-profit medical research institute focused on the systems biology of disease, today announced in a study published in the July edition of Genome Biology, that genetic matter, previously ignored by the scientific community, may play an important role in cancer.

1 Aug 2013

Convergent Dental’s Solea CO2 dental laser system receives FDA clearance

Convergent Dental, Inc., a privately held dental device and technology company, announced today that the U.S. Food and Drug Administration (FDA) has cleared Solea™ for ablation of hard tissue for caries removal and cavity preparation. Solea is the first CO2 laser technology system that has received FDA clearance for hard tissue indications.

1 Aug 2013

Researchers contribute to key step in finding cure for prion-folding diseases in humans

The work of University of Alberta researchers and their teams has contributed to an important next step in finding a cure for deadly prion-folding diseases in humans and animals.

1 Aug 2013

Researchers develop aflocculating agent to separate and remove textile dyes from the water

The European fashion industry is a huge consumer of fresh water. Estimates point to 600 million cubic meter of fresh water being consumed yearly in Europe by the textile and clothing industry; not a negligible amount.

1 Aug 2013

Rheonix, Life Technologies sign joint development agreement for molecular testing platform

Rheonix, Inc., a developer of fully automated molecular testing solutions, and Life Technologies Corp., a global leader in the life sciences tools and diagnostic markets, have entered into a joint development agreement to introduce a molecular testing platform for their Applied Markets business.

1 Aug 2013

CCTA offers alternative means of improving triage of chest pain patients: Study

A study of two sets of 894 matched Emergency Department patients presenting with chest pain revealed that the use of coronary computed tomographic angiography led to fewer hospital admissions and shorter ED stays. According to lead researcher Michael Poon, MD, of Stony Brook University School of Medicine, the findings provide evidence that CCTA offers an alternative means of improving the triage of chest pain patients.

1 Aug 2013

Researchers find new way to help surgeons more accurately plan for epilepsy surgery

A brain imaging research team led by Simon Fraser University neuroscientist Dr. Ryan D'Arcy has found a new way to help surgeons more accurately plan for surgical treatment in epilepsy.

1 Aug 2013

MIT researchers develop photometric stereo endoscopy to detect precancerous lesions

MIT researchers have developed a new endoscopy technology that could make it easier for doctors to detect precancerous lesions in the colon. Early detection of such lesions has been shown to reduce death rates from colorectal cancer, which kills about 50,000 people per year in the United States.

1 Aug 2013

Mastech Holdings enters into definitive asset purchase agreement with Accountable Healthcare Staffing

Mastech Holdings, Inc., a national provider of Information Technology and Specialized Healthcare staffing services, announced today that it has entered into a definitive asset purchase agreement with Accountable Healthcare Staffing, Inc. to sell substantially all of the assets of its Healthcare Staffing segment.

31 Jul 2013

Technology News and Research

ImmunoGen announces FDA approval of IMGN289 Investigational New Drug

UCLA researchers develop treatment approach for breast cancer metastasized to brain

BMC, BUSM and JIPMER to jointly research on tuberculosis

Portable device for point-of-care diagnostic testing to detect cancer at earliest stages

Breath analysis: Noninvasive way to quickly determine severity of bacterial infections

MAPS method could speed development of new vaccines for serious pathogens

BD reports quarterly revenues of $2.053 billion for third fiscal quarter

Sequenom CMM, CombiMatrix sign collaboration agreement to market CMA testing for NIPT

'Dark matter' in human genome may play role in cancer biology and cell death

Convergent Dental’s Solea CO2 dental laser system receives FDA clearance

Researchers contribute to key step in finding cure for prion-folding diseases in humans

Researchers develop aflocculating agent to separate and remove textile dyes from the water

Rheonix, Life Technologies sign joint development agreement for molecular testing platform

CCTA offers alternative means of improving triage of chest pain patients: Study

Researchers find new way to help surgeons more accurately plan for epilepsy surgery

MIT researchers develop photometric stereo endoscopy to detect precancerous lesions

Mastech Holdings enters into definitive asset purchase agreement with Accountable Healthcare Staffing

MiMedx Group Q2 revenue increases more than 175%

Revolutionary new neck support collars for patients with Motor Neurone Disease

Triple-S Management reports consolidated revenues of $599.8 million for Q2 2013

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News